Nuclear Medicine
AV45 (R+D)
Name:
AV45 (R&D)
Active Principle:
Florbetapir
Therapeutic Action:
It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease and other causes of cognitive impairment. It is a supplement to other diagnostic evaluations.
Nuclear Medicine
AV45 (R+D)
Name:
AV45 (R&D)
Active Principle:
Florbetapir
Therapeutic Action:
It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease and other causes of cognitive impairment. It is a supplement to other diagnostic evaluations.
